Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.2481
Oct 30 • 2:52 PM ET Dollar change+0.0151 Percentage change(6.48%)
Index
RUT
Market Cap
19.08M
Enterprise Value
1.83B
Income
-302.14M
Sales
2.65B
Book/sh
-7.16
Cash/sh
0.10
Employees
6500
IPO
Nov 01, 1982
P/E
-
Forward P/E
2.25
PEG
-
P/S
0.01
P/B
-
P/C
2.49
P/FCF
-
EV/EBITDA
6.27
EV/Sales
0.69
Quick Ratio
0.30
Current Ratio
0.41
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-3.92
EPS next Y
0.11
EPS next Q
0.01
EPS this Y
-99.67%
EPS next Y
3201.74%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-34.78% -20.10%
EPS Y/Y TTM
74.88%
Sales Y/Y TTM
-69.68%
EPS Q/Q
89.72%
Sales Q/Q
-10.07%
Insider Own
9.79%
Insider Trans
0.00%
Inst Own
91.67%
Inst Trans
16.53%
ROA
-3.53%
ROE
-198.35%
ROIC
-24.56%
Gross Margin
39.89%
Oper. Margin
1.35%
Profit Margin
-11.41%
SMA20
-17.56%
SMA50
-65.05%
SMA200
-88.92%
Trades
Shs Outstand
76.91M
Shs Float
69.37M
52W High
5.24 -95.27%
52W Low
0.19 29.90%
Volatility
13.37% 16.65%
ATR (14)
0.05
RSI (14)
24.78
Beta
1.52
Rel Volume
0.69
Avg Volume
1.85M
Volume
1,072,689
Perf Week
14.17%
Perf Month
-55.52%
Perf Quarter
-92.72%
Perf Half Y
-93.37%
Perf YTD
-91.14%
Perf Year
-95.00%
Perf 3Y
-98.23%
Perf 5Y
-99.31%
Perf 10Y
-99.23%
Prev Close
0.23
Price
0.25
Change %
6.48%
Consensus
Sell
Avg. Price Target
$1.25
Implied Upside
+403.8%
Analysts9incl. previous ratings
Rating Distribution0 Buy · 7 Hold · 2 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 11, 2026Downgrade
RRobert W. Baird
Outperform → Neutral$1.50+504.6%
Aug 11, 2026Downgrade
C logoCCitigroup
Buy → Neutral$1.50+504.6%
Nov 03, 2025Downgrade
UBS logoUUBS
Buy → Neutral$4+1,512.3%
Jul 19, 2024Upgrade
C logoCCitigroup
Neutral → Buy$24 → $19+7,558.2%
Feb 26, 2024Initiated
LLeerink Partners
Market Perform$24+9,573.5%
Jan 03, 2024Initiated
BCS logoBBarclays
Equal Weight$21+8,364.3%
Oct 13, 2022Downgrade
C logoCCitigroup
Buy → Neutral$52 → $18+7,155.1%
Oct 12, 2022Downgrade
RRobert W. Baird
Outperform → Neutral$62 → $22+8,767.4%
Oct 12, 2022Downgrade
BAC logoBBofA Securities
Buy → Underperform$43 → $17+6,752.1%
Apr 26, 2022Resumed
C logoCCitigroup
Buy$55+22,068.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coliseum Capital Management, L 10% Stockholder Sep 11 '26Proposed Sale1.0810,726,75911,584,900Sep 11 04:30 PM
Accendra Health, Inc. engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Its brands include Apria and Byram Healthcare. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.
PresidentMr. Kenneth Gardner-Smith
Executive VPMr. Jonathan A. Leon
Executive VP & COOMr. Perry A. Bernocchi
Executive VPMr. Heath H. Galloway
Senior VP & Chief Information OfficerMr. Nicholas Piecora